MATERIAL SAFETY DATA SHEET - Lupin …
MSDS : 033/01 Page 3 of 6 Effective Date : 30/01/2014 6.
Download MATERIAL SAFETY DATA SHEET - Lupin …
Information
Domain:
Source:
Link to this page:
Documents from same domain
MATERIAL SAFETY DATA SHEET - Lupin …
www.lupinpharmaceuticals.comMSDS : 001/01 Effective Date : 03.03.2004 Page 3 of 5
CEFDINIR FOR ORAL SUSPENSION USP 125 mg/5 …
www.lupinpharmaceuticals.comCEFDINIR FOR ORAL SUSPENSION USP 125 mg/5 mL & 250 mg/5 mL Rx only To reduce the development of drug-resistant bacteria and maintain the …
MATERIAL SAFETY DATA SHEET - Lupin …
www.lupinpharmaceuticals.commsds : 076/00 effective date : 06/09/2012 page 4 of 5 11. toxicological information 13. disposal consideration 10. stability and reactivity 12. ecological information
MSDS - Azithromycin Tablets 250 mg and 500 mg …
www.lupinpharmaceuticals.comMSDS : 122/00 Page 2 of 5
MATERIAL SAFETY DATA SHEET - Lupin …
www.lupinpharmaceuticals.comMSDS : 019/01 Page 2 of 5 Effective Date : 27/01/2014
The oral suspension produces average peak …
www.lupinpharmaceuticals.comIn subjects with moderate impairment of renal function (20 to 40 mL/min creatinine clearance), the average serum half-life of cefixime is prolonged to 6.4 hours.
Lisinopril Tablets USP PI - Lupin Pharmaceuticals
www.lupinpharmaceuticals.comPage 1 of 16 Lisinopril Tablets USP 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Rx only DESCRIPTION Lisinopril is an oral long-acting …
MATERIAL SAFETY DATA SHEET - Lupin …
www.lupinpharmaceuticals.comMSDS : 024/02 Page 4 of 6 Effective Date : 13/03/2014 11.
MATERIAL SAFETY DATA SHEET - Lupin …
www.lupinpharmaceuticals.comMSDS : 024/00 Effective Date : 03/07/2007 Page 2 of 5 4. FIRST AID MEASURES Ingestion Never attempt to induce vomiting. Do not attempt to give any solid or liquid by mouth if the exposed subject is unconscious or semi-
Related documents
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euEach film-coated tablet contains 250 mg levetiracetam. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM
New Zealand Data Sheet - Medsafe
www.medsafe.govt.nzNew Zealand Data Sheet . In vitro, Levetiracetam and its primary metabolite have been shown not to inhibit the major human liver cytochrome P. 450
LEVETIRACETAM 250 MG, 500 MG, 750 MG AND …
www.mhra.gov.ukUKPAR – Levetiracetam 250mg, 500mg, 750mg & 1000 mg Film-Coated Tablets Tablets PL 14017/0228-0231 -2 - LEVETIRACETAM 250 MG, 500 MG…
Post-Operative Instructions for Patients after …
www.sd-neurosurgeon.comPost-Operative Instructions for Patients after Craniotomy Here are some suggestions for care after a craniotomy (head operation). We realize that it is impossible to anticipate all of the questions or problems that may
LEVETIRACETAM Keppra® Vial 100 mg/mL, …
www.segurneo.esLEVETIRACETAM Keppra® Vial 100 mg/mL, solución v.o. 100 mg/mL y comprimidos 250 y 500 mg DOSIS 10 mg/Kg/dosis v.o., i.v. en 15 min a concentración 5 mg/mL Ajustar dosis según necesidad cada 1-2 sem